Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBTX | AZN | AMGN | GILD | BMY |
| Company | Nanobiotix S.A. ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 33.98 | 193.96 | 368.24 | 146.52 | 60.13 |
| High | 34.00 | 193.96 | 368.78 | 146.71 | 60.81 |
| Low | 31.59 | 190.95 | 359.80 | 143.27 | 59.59 |
| Latest | 32.08 | 191.29 | 361.13 | 144.40 | 59.71 |
| Change | -1.92 | -0.72 | -5.12 | -0.81 | unch |
| % Change | -5.65% | -0.37% | -1.40% | -0.56% | unch |
| Volume | 65,900 | 1,455,500 | 2,334,300 | 3,887,900 | 14,258,000 |
| 20-Day Average Volume | 53,640 | 1,937,280 | 2,504,325 | 6,340,045 | 12,243,109 |
| Previous Close | 34.00 | 192.01 | 366.25 | 145.21 | 59.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.06 | 199.95 | 375.73 | 147.44 | 60.67 |
| 20-Day Raw Stochastic | 43.62% | 8.30% | 4.22% | 12.91% | 30.44% |
| 20-Day Relative Strength | 55.70 | 45.62 | 48.07 | 51.20 | 53.12 |
| Weighted Alpha | +528.32 | +30.43 | +20.62 | +38.74 | +10.42 |
| Today's Opinion | 100% Buy | 56% Buy | 80% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.00% since 03/10/26 | -1.90% since 03/10/26 | -3.81% since 03/10/26 | -2.80% since 03/10/26 | -0.70% since 03/10/26 |
| Low | 31.33 on 03/12/26 | 189.43 on 03/13/26 | 359.80 on 03/17/26 | 142.68 on 03/16/26 | 58.32 on 03/12/26 |
| High | 36.54 on 03/11/26 | 194.83 on 03/11/26 | 380.14 on 03/11/26 | 149.30 on 03/11/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | +21.01% since 02/17/26 | -8.68% since 02/17/26 | -3.28% since 02/17/26 | -7.00% since 02/17/26 | -1.06% since 02/17/26 |
| Low | 24.49 on 02/23/26 | 189.35 on 03/09/26 | 359.80 on 03/17/26 | 142.68 on 03/16/26 | 58.32 on 03/12/26 |
| High | 41.89 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +49.63% since 12/17/25 | +6.44% since 12/17/25 | +10.77% since 12/17/25 | +18.98% since 12/17/25 | +11.50% since 12/17/25 |
| Low | 19.61 on 01/12/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 41.89 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +214.43% since 09/17/25 | +23.11% since 09/17/25 | +31.46% since 09/17/25 | +28.63% since 09/17/25 | +29.38% since 09/17/25 |
| Low | 10.58 on 09/19/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 41.89 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,645,634 | 297,789,824 | 197,433,664 | 180,266,752 | 121,597,856 |
| Shares Outstanding, K | 48,401 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | -7,780,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -73,730,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.62 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/01/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.73 | 16.76 | 17.79 | 9.61 |